3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Specimen Handling
3
Taxes
2
Carboplatin
2
pegfilgrastim
1
olaparib
1
X-Rays
1
Therapeutics
1
Radiotherapy
1
Radiation
1
Panitumumab
1
Palliative Care
1
Paclitaxel
1
Methods
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Indocyanine Green
1
Exercise Test
1
Epirubicin
1
Educational Status
1
Early Intervention, Educational
1
Docetaxel
1
Clostridium perfringens epsilon-toxin
1
Albumin-Bound Paclitaxel
1
Accelerometry
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Inflammatory Breast Neoplasms
×
tipifarnib
×
90 days
×
Clear all
No trials found.